| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VIROL.2012.08.035 |
| P8608 | Fatcat ID | release_ry75nx4otjhddevd5eblytaluy |
| P932 | PMC publication ID | 3552393 |
| P698 | PubMed publication ID | 22985477 |
| P5875 | ResearchGate publication ID | 230869454 |
| P50 | author | Christopher B. Buck | Q30470487 |
| Richard B S Roden | Q87305927 | ||
| Kihyuck Kwak | Q89793910 | ||
| P2093 | author name string | Cynthia D Thompson | |
| Douglas R Lowy | |||
| John T Schiller | |||
| Patricia M Day | |||
| Alessandra Handisurya | |||
| P2860 | cites work | Cutaneous and mucosal human papillomaviruses differ in net surface charge, potential impact on tropism | Q21245129 |
| Current understanding of the mechanism of HPV infection | Q24616134 | ||
| Heparan sulfate: decoding a dynamic multifunctional cell regulator | Q31882323 | ||
| Different papillomaviruses have different repertoires of transcription factor binding sites: convergence and divergence in the upstream regulatory region | Q33235943 | ||
| Alpha 6 beta 4 integrin heterodimer is a component of hemidesmosomes | Q33899956 | ||
| Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan | Q34004909 | ||
| Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments | Q34021545 | ||
| In Vivo Mechanisms of Vaccine-Induced Protection against HPV Infection | Q34125906 | ||
| Preclinical model to test human papillomavirus virus (HPV) capsid vaccines in vivo using infectious HPV/cottontail rabbit papillomavirus chimeric papillomavirus particles | Q35185992 | ||
| Human papillomavirus infections and oral tumors | Q35200632 | ||
| Rapidly enlarging growth of the proximal nail fold | Q35203869 | ||
| Transcriptional activation of the human papillomavirus type 5 and 16 long control region in cells from cutaneous and mucosal origin | Q35688469 | ||
| Papillomavirus capsid binding and uptake by cells from different tissues and species. | Q35831992 | ||
| Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells | Q35839345 | ||
| A protective and broadly cross-neutralizing epitope of human papillomavirus L2. | Q36315086 | ||
| Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2. | Q36545925 | ||
| Interaction of papillomaviruses with the cell surface | Q36637073 | ||
| Tissue site-specific enhancer function of the upstream regulatory region of human papillomavirus type 11 in cultured keratinocytes. | Q36781076 | ||
| Heterogeneity of the human papillomavirus group. | Q36831751 | ||
| Efficient intracellular assembly of papillomaviral vectors | Q36944399 | ||
| Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus | Q37099713 | ||
| Epidermodysplasia verruciformis and human papilloma virus | Q37100931 | ||
| The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding | Q37453403 | ||
| Human papillomavirus type 26 infection causing multiple invasive squamous cell carcinomas of the fingernails in an AIDS patient under highly active antiretroviral therapy | Q37604419 | ||
| Mucosal human papillomavirus types in squamous cell carcinomas of the uterine cervix and subsequently on fingers | Q38464809 | ||
| Nuclear location of minor capsid protein L2 is required for expression of a reporter plasmid packaged in HPV51 pseudovirions | Q39797494 | ||
| Diversity of human papillomavirus types in periungual squamous cell carcinoma | Q39896102 | ||
| Cutaneous human papillomavirus in head and neck squamous cell carcinomas | Q39972408 | ||
| Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. | Q40572162 | ||
| Wounding prior to challenge substantially improves infectivity of cottontail rabbit papillomavirus and allows for standardization of infection | Q41909714 | ||
| Novel Laboratory Mouse Papillomavirus (MusPV) Infection | Q44785420 | ||
| Human papillomavirus type 26-associated periungual squamous cell carcinoma in situ in a HIV-infected patient with concomitant penile and anal intraepithelial neoplasia | Q45053936 | ||
| Verruca vulgaris of the vulva in children and adults: a nonvenereal type of vulvar wart | Q80110722 | ||
| Production of papillomavirus-based gene transfer vectors | Q80568642 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 385-394 | |
| P577 | publication date | 2012-09-15 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and species | |
| P478 | volume | 433 |
| Q35150470 | A potent combination microbicide that targets SHIV-RT, HSV-2 and HPV |
| Q42268011 | Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial |
| Q28607775 | Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach |
| Q37336676 | Characterization of Mus musculus papillomavirus 1 infection in situ reveals an unusual pattern of late gene expression and capsid protein localization |
| Q37619334 | Cutaneous HPV8 and MmuPV1 E6 Proteins Target the NOTCH and TGF-β Tumor Suppressors to Inhibit Differentiation and Sustain Keratinocyte Proliferation. |
| Q46237480 | Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1). |
| Q64887908 | Diverse Papillomavirus Types Induce Endosomal Tubulation. |
| Q91466951 | Hand-to-genital and genital-to-genital transmission of human papillomaviruses between male and female sexual partners (HITCH): a prospective cohort study |
| Q36470809 | Human papillomavirus capsids preferentially bind and infect tumor cells |
| Q34774775 | Human papillomavirus species-specific interaction with the basement membrane-resident non-heparan sulfate receptor |
| Q39229099 | Human papillomavirus type 16 pseudovirions with few point mutations in L1 major capsid protein FG loop could escape actual or future vaccination for potential use in gene therapy |
| Q34634389 | Immune status, strain background, and anatomic site of inoculation affect mouse papillomavirus (MmuPV1) induction of exophytic papillomas or endophytic trichoblastomas |
| Q40829202 | MmuPV1 infection and tumor development of T cell-deficient mice is prevented by passively transferred hyperimmune sera from normal congenic mice immunized with MmuPV1 virus-like particles (VLPs). |
| Q89685649 | MmuPV1: A New Frontier in Animal Models of Papillomavirus Pathogenesis |
| Q35166924 | Papillomaviruses: Viral evolution, cancer and evolutionary medicine |
| Q28611356 | Production of Furin-Cleaved Papillomavirus Pseudovirions and Their Use for In Vitro Neutralization Assays of L1- or L2-Specific Antibodies |
| Q46251800 | Rodent Papillomaviruses. |
| Q27313673 | Role of Ultraviolet Radiation in Papillomavirus-Induced Disease |
| Q54216752 | Roles of Fc domain and exudation in L2 antibody-mediated protection against human papillomavirus. |
| Q27324289 | Strain-specific properties and T cells regulate the susceptibility to papilloma induction by Mus musculus papillomavirus 1 |
| Q34408919 | Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a µ genotype |
| Q47633934 | T cell-mediated antitumor immune response eliminates skin tumors induced by mouse papillomavirus, MmuPV1. |
| Q35624920 | The HPV16 and MusPV1 papillomaviruses initially interact with distinct host components on the basement membrane |
| Q47111581 | The full transcription map of mouse papillomavirus type 1 (MmuPV1) in mouse wart tissues. |
Search more.